Ellevest Inc’s Anavex Life Sciences AVXL Stock Holding History

Ellevest Inc’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25	Closed	–	–	1398
2022 Q1	$0	Hold	25	–	–	﹤0.01%	1415
2021 Q4	$0	Hold	25	–	–	﹤0.01%	1410
2021 Q3	$0	Buy	25 +2	+9%	+$40	﹤0.01%	1400
2021 Q2	$1K	Buy	+23	New	+$341	﹤0.01%	1119

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Ellevest Inc's AVXL Position: Q2 2022 in Review

Ellevest Inc sold out of Anavex Life Sciences (AVXL) in Q2 2022, closing a stake of 25 shares.

Ellevest Inc first reported a position in AVXL in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q2 2021. 150 funds tracked by Wall St. Rank hold AVXL as of Q2 2022.

Ellevest Inc reported no remaining Anavex Life Sciences position as of Q2 2022 after selling out during the quarter.
Ellevest Inc sold 25 Anavex Life Sciences shares in Q2 2022.
Ellevest Inc first reported a position in Anavex Life Sciences in Q2 2021 and held it in 4 quarters.
Ellevest Inc's Anavex Life Sciences position peaked at $1K in Q2 2021.
150 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.